Autolus Therapeutics plc AUTL
Autolus Therapeutics plc statistics & valuation
Market cap$423.2M
P / S5.6×
P / B2.4×
Net margin-381.4%
Return on equity-161.4%
FCF margin-401.4%
Return on capital-52.5%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -358.9% | -2385.6% | -10583.1% | — | — | — | -5022.8% | -4089.1% | — | -1383.2% |
| Net margin | -381.4% | -2180.5% | -12272.3% | — | — | — | -4258.9% | -3180.6% | — | -1165.2% |
| FCF margin | -401.4% | -2256.4% | -9221.0% | — | — | — | -4120.5% | -2889.6% | — | -1136.2% |
| Return on assets | -48.8% | -28.2% | -55.5% | -30.4% | -35.0% | -48.3% | -40.8% | -16.4% | -13.8% | -13.3% |
| Return on equity | -161.4% | -51.6% | -186.9% | -49.8% | -45.4% | -67.7% | -48.6% | -17.5% | -14.3% | -13.8% |
| Debt / equity | — | — | — | — | — | — | 0.00× | 0.00× | — | 0.01× |
| Current ratio | 5.94 | 10.88 | 6.15 | 9.18 | 12.15 | 5.86 | 9.98 | 15.13 | — | 28.31 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.